Dual responsive hydroxyapatite capped mesoporous silica nanoparticles for controlled delivery of Palbociclib to treat osteosarcoma-Reference-Cited by-同舟云学术

Dual responsive hydroxyapatite capped mesoporous silica nanoparticles for controlled delivery of Palbociclib to treat osteosarcoma

Published:2023-04 Issue: Volume:82 Page:104356
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Heydari Seyed Reza,Samadi Mahnoush,Shirangi Armina^ORCID,Farokhi Mehdi,Moradi Ayda^ORCID,Bafkary Reza,Atyabi Fatemeh,Mottaghitalab Fatemeh,Dinarvand Rassoul^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference32 articles.

1. Osteosarcoma: a surveillance, epidemiology, and end results program-based analysis from 1975 to 2017;Cole;Cancer,2022

2. Osteosarcoma: a review of diagnosis, management, and treatment strategies;Geller;Clin. Adv. Hematol. Oncol.,2010

3. Osteosarcoma overview;Lindsey;Rheumatol Ther,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PEGylated mesoporous silica core–shell redox-responsive nanoparticles for delivering paclitaxel to breast cancer cells;International Journal of Pharmaceutics;2024-04

2. Material and Design Toolkit for Drug Delivery: State of the Art, Trends, and Challenges;ACS Applied Materials & Interfaces;2023-11-23

3. Aptamer-modified chitosan-capped mesoporous silica nanoparticles for co-delivery of cytarabine and daunorubicin in leukemia;International Journal of Pharmaceutics;2023-11

4. An Insight into Mesoporous Silica Nanoparticles: Ray of Hope for Cancer Management;Current Cancer Therapy Reviews;2023-10-10